EBS vs HSIC · rev $390.4M vs P/E 24, rev $6.83B
Emergent Biosolutions Inc (EBS) versus Henry Schein Inc (HSIC) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Latest reported EBS revenue for 2026-06-30 was $390.4M. Net income was -$173.4M. EBS currently screens at market cap $416.4M.
Latest reported HSIC revenue for 2026-06-27 was $6.83B. Net income was $201.0M. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
EBS currently screens at market cap $416.4M. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Not investment advice. Open the EBS and HSIC stock pages for the full models.
Not investment advice.